Budge brings 25 years of CFO experience across a range of public and private high-growth technology companies.
In this role, he will be responsible for the company's financial strategy, driving quarterly performance, and stewarding sustainable growth to make high-quality care more accessible and affordable.
Budge joins Hinge Health at a time of unprecedented momentum. Following the company's strong Series E funding, Hinge Health published the largest medical claims analysis ever performed for a digital musculoskeletal (MSK) solution, showing a 2.4x ROI, and surpassed its 1,000 enterprise customer milestone – closing more new customers in 2022 than the prior 7 years combined.
Strategic acquisitions, including Enso and wrnch, further established Hinge Health's technology portfolio as the most advanced in the industry, able to deliver the market's leading member experience and strongest outcomes.
Budge most recently served as CFO of Automation Anywhere, where he led the company's efforts toward profitability.
His career has centered on serving as CFO to accelerate growth for public and late-stage private companies.
Over his career, he has raised billions in capital, taken multiple companies public, overseen dozens of acquisitions, and led numerous efforts to improve critical infrastructure. Budge holds a bachelor's in accounting from Brigham Young University and currently sits on the board of Shadowbox.
Hinge Health pairs advanced motion technology and wearable pain relief with a complete clinical care team of physical therapists, physicians, and board-certified health coaches to help people move beyond pain and reduce surgeries and opioid use.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar